Rendoscopy, Inc., a developer of advanced 3-D visualization software, announced that the FDA has given 510(k) market clearance to its Gentle Colon virtual colonoscopy application, designed to offer a speedy solution to the market.
Gentle Colon can reportedly achieve faster rendering speeds than other virtual colonscopy solutions via its virtual fly-through mode. The software provides the flattened view and the split-colon view and generates 2-D and 3-D views on a single user interface.
“I am using the software or examining the cases that were acquired through various clinical trials. Particularly impressive is its fast rendering speed in the virtual fly-through mode—probably one of the fastest among those that provide similar functions,” said Hiro Yoshida, M.D., associate professor of Radiology at Harvard Medical School and the director of 3-D Imaging Research at the Massachusetts General Hospital. “Also impressive is its capability of providing, on a single platform, the majority of the visualization methods of the colon proposed in the virtual colonoscopy community, such as the flattened view and the split-colon view. The wide spectrum of visualization modes makes Rendoscopy a very attractive all-in-one tool for virtual colonoscopy examinations.”
Related Content
News | ACR
February 6, 2024 — An update to the CT Colonography Reporting and Data System (C-RADS) has been published Jan. 30 in the ...
February 06, 2024 
News | Colonoscopy Systems
A team of Johns Hopkins data researchers is studying the economic and safety implications associated with the devices used to perform colonoscopies as a disposable version inches closer to widespread availability.
August 26, 2019 
News | Colonoscopy Systems
A new study finds that trends in colonoscopy rates did not fully align with the increase in colorectal cancer (CRC) in younger adults, adding to evidence that the rise in early onset CRC is not solely a result of more detection. The study is published early online in the Journal of Medical Screening.
August 06, 2019 
News | Colonoscopy Systems
Check-Cap Ltd. has initiated its U.S. pilot study of the C-Scan system for prevention of colorectal cancer through detection of precancerous polyps, following Institutional Review Board (IRB) approval and full Investigational Device Exemption (IDE) application approval by the U.S. Food and Drug Administration (FDA). The first patients have ingested C-Scan, a preparation-free capsule, at the New York University School of Medicine.
April 15, 2019 
News | Colonoscopy Systems
https://www.congress.gov/bill/115th-congress/house-bill/1298?q=%7B%22se… cancer care advocacy groups and medical societies are calling on Congress to pass the CT Colonography Screening for Colorectal Cancer Act (S.3465/HR 1298). The bipartisan bill introduced in the U.S. Senate September 19 would provide Medicare coverage for screening computed tomography colonography (CTC), commonly known as virtual colonoscopy.
September 27, 2018 
News | Colonoscopy Systems
Check-Cap Ltd. announced the interim results for its post-CE approval study of the C-Scan system Version 3, an ingestible, capsule-based device for preparation-free colorectal cancer (CRC) screening. The company said data from the multicenter clinical investigation showed promising results for detecting patients with polyps in an un-prepped colon.
September 04, 2018 
News | Colonoscopy Systems
An updated American Cancer Society guideline says colorectal cancer screening should begin at age 45 for people at average risk. The recommendation is based in part on data showing rates of colorectal cancer are increasing in young and middle-aged populations.
May 30, 2018 
News | Colonoscopy Systems
February 8, 2018 – The U.S. Food and Drug Administration (FDA) announced on February 7, 2018, that Pentax Medical’s ...
February 08, 2018 
News | Colonoscopy Systems
August 31, 2017 — A fast, simple blood test for ulcerative colitis using infrared spectroscopy could provide a cheaper ...
August 31, 2017 
News | Colonoscopy Systems
People with insurance policies that cover computed tomography (CT) colonography for colorectal cancer screening are almost 50 percent more likely to get screened than those whose policies don’t cover the procedure, according to a new study appearing online in the journal Radiology.
July 12, 2017 © Copyright Wainscot Media. All Rights Reserved.
Subscribe Now